Physician profile
John D Rowley
NPI 1295781011
$572.86
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.53 · 2022: $39.96 · 2023: $237 · 2024: $93.59 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $146.26 | 2021-2025 | Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.30 | 2022-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $38.99 | 2024-2025 | Verquvo |
| Amgen INC. | $31.22 | 2024-2025 | Repatha, Repatha |
| Atricure, INC. | $28.69 | 2023 | |
| Bridgebio Pharma, INC. | $18.09 | 2025 | Attruby |
| Scpharmaceuticals INC. | $17.73 | 2025 | |
| Boston Scientific Corporation | $15.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.